Newswire
ภาษาไทย
English-
CISION PR Newswire - Silicon Motion Unveils New USB Display Interface S...
The SM770 supports up to three 4K 60Hz UHD displays and up to 144Hz display, allowing flexible connections with PC notebooks, ideally for commercial use, shared office users, and gamers. TAIPEI and MI... -
CISION PR Newswire - The Seasons Games - An immersive experience at the...
PARIS, June 3, 2024 /PRNewswire/ -- A spectacular, never-before-seen 30-minute experience will open on the Champs-Élysées on 7 June 2024. The seasons games The Théâtre du Lido offers visito... -
CISION PR Newswire - GenFleet Therapeutics Announces Efficacy & Saf...
SHANGHAI and CHICAGO, June 2, 2024 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today announced the phas... -
CISION PR Newswire - Immunofoco Biotech to Unveil Solid Tumor CAR-T Pro...
CHICAGO, June 2, 2024 /PRNewswire/ -- On June 1st, 2024, Immunofoco Biotech, a company dedicated to developing cell therapy products for solid tumors, announced that the clinical research data for two... -
CISION PR Newswire - Z Grills Announces Unprecedented "Buy 1, Get 10 Gr...
ONTARIO, Calif., June 1, 2024 /PRNewswire/ -- Mark your calendars, grill masters! Z Grills, the innovator in premium wood pellet grills, is sizzling up summer with a groundbreaking promotion that's su... -
CISION PR Newswire - ICECO Launches APL35 on Indiegogo - The World's Li...
BREA, Calif., June 1, 2024 /PRNewswire/ -- ICECO, a leading expert in portable refrigeration solutions, announces the launch of the world's lightest dual-zone aluminum portable freezer, the APL35, on ... -
CISION PR Newswire - Tag along with Jason in Zhengzhou: Experiencing Ku...
BEIJING, May 30, 2024 /PRNewswire/ -- This is a report from China.org.cn about the Shaolin Temple:  Guided by a friend who trains at the Shaolin Temple, Jason Castleton visit... -
CISION PR Newswire - Immunocan Launches Innovative Alpaca-derived Nanob...
BOSTON, June 1, 2024 /PRNewswire/ -- Immunocan announces significant progress in the construction of its alpaca-derived nanobody discovery platform, ImmuAlpaca® mouse. The IGH-VDJ genes in the mouse g... -
CISION PR Newswire - TiumBio Presents Phase 1b Interim Results for TU22...
Poster presentation features the interim data from an ongoing Phase 1b clinical trial of TU2218 plus Keytruda combination therapy in patients with advanced solid tumors A 4... -
CISION PR Newswire - Ivonescimab in Combination with Chemotherapy Appro...
Separate & Distinct from HARMONi-2 Announcement, HARMONi-A Showed Clinically Meaningful and Statistically Significant Benefit: PFS Hazard Ratio of 0.46 For Subset of Patients Previously Receiving...
The information provided in this article was created by CISION PR Newswire, our news partner. The author's opinions and the content shared on this page are their own and may not necessarily represent the perspectives of ELITE Beauty.